| An atlas of genetic correlations across human diseases and traits B Bulik-Sullivan, HK Finucane, V Anttila, A Gusev, FR Day, PR Loh, ... Nature genetics 47 (11), 1236-1241, 2015 | 3516 | 2015 |
| Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder D Demontis, RK Walters, J Martin, M Mattheisen, TD Als, E Agerbo, ... Nature genetics 51 (1), 63-75, 2019 | 2132 | 2019 |
| Identification of common genetic risk variants for autism spectrum disorder J Grove, S Ripke, TD Als, M Mattheisen, RK Walters, H Won, J Pallesen, ... Nature genetics 51 (3), 431-444, 2019 | 1906 | 2019 |
| Large-scale exome sequencing study implicates both developmental and functional changes in the neurobiology of autism FK Satterstrom, JA Kosmicki, J Wang, MS Breen, S De Rubeis, JY An, ... Cell 180 (3), 568-584. e23, 2020 | 1759 | 2020 |
| Insights into autism spectrum disorder genomic architecture and biology from 71 risk loci SJ Sanders, X He, AJ Willsey, AG Ercan-Sencicek, KE Samocha, ... Neuron 87 (6), 1215-1233, 2015 | 1483 | 2015 |
| Analysis of shared heritability in common disorders of the brain Brainstorm Consortium, V Anttila, B Bulik-Sullivan, HK Finucane, ... Science 360 (6395), eaap8757, 2018 | 1372 | 2018 |
| A framework for the interpretation of de novo mutation in human disease KE Samocha, EB Robinson, SJ Sanders, C Stevens, A Sabo, LM McGrath, ... Nature genetics 46 (9), 944-950, 2014 | 1090 | 2014 |
| Examining and interpreting the female protective effect against autistic behavior EB Robinson, P Lichtenstein, H Anckarsäter, F Happé, A Ronald Proceedings of the National Academy of Sciences 110 (13), 5258-5262, 2013 | 564 | 2013 |
| Polygenic transmission disequilibrium confirms that common and rare variation act additively to create risk for autism spectrum disorders DJ Weiner, EM Wigdor, S Ripke, RK Walters, JA Kosmicki, J Grove, ... Nature genetics 49 (7), 978, 2017 | 471 | 2017 |
| Genetic risk for autism spectrum disorders and neuropsychiatric variation in the general population EB Robinson, B St Pourcain, V Anttila, JA Kosmicki, B Bulik-Sullivan, ... Nature genetics 48 (5), 552-555, 2016 | 438 | 2016 |
| Genetic Consortium for Anorexia Nervosa of the Wellcome Trust Case Control Consortium 3. An atlas of genetic correlations across human diseases and traits B Bulik-Sullivan, HK Finucane, V Anttila Nat Genet 47 (11), 1236-1241, 2015 | 398 | 2015 |
| Evidence that autistic traits show the same etiology in the general population and at the quantitative extremes (5%, 2.5%, and 1%) EB Robinson, KC Koenen, MC McCormick, K Munir, V Hallett, F Happé, ... Archives of general psychiatry 68 (11), 1113-1121, 2011 | 370 | 2011 |
| Meta-analysis of GWAS of over 16,000 individuals with autism spectrum disorder highlights a novel locus at 10q24. 32 and a significant overlap with schizophrenia Molecular autism 8, 1-17, 2017 | 344 | 2017 |
| Refining the role of de novo protein-truncating variants in neurodevelopmental disorders by using population reference samples JA Kosmicki, KE Samocha, DP Howrigan, SJ Sanders, K Slowikowski, ... Nature genetics 49 (4), 504-510, 2017 | 335 | 2017 |
| Prenatal antidepressant exposure is associated with risk for attention-deficit hyperactivity disorder but not autism spectrum disorder in a large health system CC Clements, VM Castro, SR Blumenthal, HR Rosenfield, SN Murphy, ... Molecular psychiatry 20 (6), 727-734, 2015 | 242 | 2015 |
| Predicting polygenic risk of psychiatric disorders AR Martin, MJ Daly, EB Robinson, SE Hyman, BM Neale Biological psychiatry 86 (2), 97-109, 2019 | 240 | 2019 |
| In vivo Perturb-Seq reveals neuronal and glial abnormalities associated with autism risk genes X Jin, SK Simmons, A Guo, AS Shetty, M Ko, L Nguyen, V Jokhi, ... Science 370 (6520), eaaz6063, 2020 | 218 | 2020 |
| Autism spectrum disorder and attention deficit hyperactivity disorder have a similar burden of rare protein-truncating variants FK Satterstrom, RK Walters, T Singh, EM Wigdor, F Lescai, D Demontis, ... Nature neuroscience 22 (12), 1961-1965, 2019 | 205 | 2019 |
| Tumor cell-derived extracellular vesicle-coated nanocarriers: an efficient theranostic platform for the cancer-specific delivery of anti-miR-21 and imaging agents R JC Bose, S Uday Kumar, Y Zeng, R Afjei, E Robinson, K Lau, ... ACS nano 12 (11), 10817-10832, 2018 | 184 | 2018 |
| A genetic investigation of sex bias in the prevalence of attention-deficit/hyperactivity disorder J Martin, RK Walters, D Demontis, M Mattheisen, SH Lee, E Robinson, ... Biological psychiatry 83 (12), 1044-1053, 2018 | 183 | 2018 |
Mark DalyDirector, Institute for Molecular Medicine Finland (FIMM) & Chief, ATGU, MGH & Broad Institute在 atgu.mgh.harvard.edu 的电子邮件经过验证
